Advancements In Targeted mRNA Delivery
Source: Sartorius
mRNA has broad potential as a therapeutic. The clinical translation of mRNA therapeutics has been made possible through advances in the design of mRNA manufacturing and intracellular delivery methods. However, broad application of mRNA is still limited by the need for improved delivery systems.
Now available On-Demand, Cell & Gene Live guests Dr. Murat Kalayoglu, CEO of Cartesian Therapeutics and Walter Strapps, Ph.D., CSO of Gemini Therapeutics and Co-Founder and CEO of Carver Biosciences explain the delivery of mRNA-based therapeutics and the specific challenges, opportunities, and advancements in delivering mRNA therapeutics clinically.
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Cell & Gene? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Sartorius
This website uses cookies to ensure you get the best experience on our website. Learn more